EP2019663A2 - Zusammensetzungen mit mindestens einem naphthoesäurederivat und benzoylperoxid, herstellungsverfahren und verwendung - Google Patents

Zusammensetzungen mit mindestens einem naphthoesäurederivat und benzoylperoxid, herstellungsverfahren und verwendung

Info

Publication number
EP2019663A2
EP2019663A2 EP07766070A EP07766070A EP2019663A2 EP 2019663 A2 EP2019663 A2 EP 2019663A2 EP 07766070 A EP07766070 A EP 07766070A EP 07766070 A EP07766070 A EP 07766070A EP 2019663 A2 EP2019663 A2 EP 2019663A2
Authority
EP
European Patent Office
Prior art keywords
naphthoic acid
benzoyl peroxide
derivative
composition
encapsulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07766070A
Other languages
English (en)
French (fr)
Inventor
Laurent Fredon
Nathalie Willcox
Sandrine Segura-Orsoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of EP2019663A2 publication Critical patent/EP2019663A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
EP07766070A 2006-05-17 2007-05-16 Zusammensetzungen mit mindestens einem naphthoesäurederivat und benzoylperoxid, herstellungsverfahren und verwendung Withdrawn EP2019663A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604407A FR2901139B1 (fr) 2006-05-17 2006-05-17 Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
PCT/FR2007/051296 WO2007132134A2 (fr) 2006-05-17 2007-05-16 Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations

Publications (1)

Publication Number Publication Date
EP2019663A2 true EP2019663A2 (de) 2009-02-04

Family

ID=37561252

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07766070A Withdrawn EP2019663A2 (de) 2006-05-17 2007-05-16 Zusammensetzungen mit mindestens einem naphthoesäurederivat und benzoylperoxid, herstellungsverfahren und verwendung

Country Status (5)

Country Link
US (1) US20090191245A1 (de)
EP (1) EP2019663A2 (de)
CA (1) CA2649124A1 (de)
FR (1) FR2901139B1 (de)
WO (1) WO2007132134A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2903603B1 (fr) 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
CN102686208A (zh) * 2009-10-07 2012-09-19 塔格拉生物科技有限公司 包含过氧化苯甲酰的微胶囊和包含所述微胶囊的局部用组合物
RU2572693C2 (ru) * 2009-10-21 2016-01-20 Дау Фармасьютикал Сайенсиз, Инк. Способ смачивания порошка, содержащего пероксид бензоила
US9744150B2 (en) * 2009-10-21 2017-08-29 Dow Pharmaceutical Sciences Inc. Suspension containing micronized benzoyl peroxide
SG10202100745QA (en) * 2014-04-01 2021-02-25 Galderma Res & Dev Combination of adapalene and benzoyl peroxide for treating acne scars
WO2017068673A1 (ja) * 2015-10-21 2017-04-27 マルホ株式会社 皮膚用の医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007132134A2 *

Also Published As

Publication number Publication date
US20090191245A1 (en) 2009-07-30
WO2007132134A3 (fr) 2008-01-10
WO2007132134A2 (fr) 2007-11-22
FR2901139B1 (fr) 2009-03-20
FR2901139A1 (fr) 2007-11-23
CA2649124A1 (fr) 2007-11-22

Similar Documents

Publication Publication Date Title
EP2019663A2 (de) Zusammensetzungen mit mindestens einem naphthoesäurederivat und benzoylperoxid, herstellungsverfahren und verwendung
EP2364692B1 (de) Zusammensetzungen, die mindestens ein Naphtoesäurederivat, Benzoylperoxid und mindestens eine filmbildende Substanz enthalten, ihre Herstellungsverfahren und ihre Anwendungen
FR2909000A1 (fr) Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
JP5074401B2 (ja) 少なくとも１つのナフトエ酸誘導体および少なくとも１つのポリウレタンポリマータイプの化合物またはその誘導体を含む組成物、その調製方法、およびその使用
FR2910320A1 (fr) Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321A1 (fr) Gel creme comprenant au moins un retinoide et du peroxyde de benzole
US8709392B2 (en) Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
CA2568262A1 (fr) Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
FR2916975A1 (fr) Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
EP1965872A2 (de) Zusammensetzungen mit mindestens einer retinoid-verbindung und mindestens einer reizhemmenden verbindung sowie anwendungen davon
FR2916966A1 (fr) Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
EP1965786B1 (de) Zusammensetzungen mit mindestens einer retinoid-verbindung und mindestens einer reizhemmenden verbindung sowie anwendungen davon
EP2029133B1 (de) Zusammensetzungen mit mindestens einem naphthoesäurederivat und mindestens einem filmbildenden mittel, herstellungsverfahren und verwendung
EP2104496A2 (de) Verwendung von nepafenac oder derivaten davon zur behandlung von hauterkrankungen in verbindung mit einem keratinisationsleiden einschliesslich einer immunallergischen entzündungskomponente

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081217

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20110921

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160913